The Evolution of Cervical Screening and the Specialty of Obstetrics and Gynecology
The Evolution of Cervical Screening and the Specialty of Obstetrics and Gynecology
复制标题
DOI：
10.1097/aog.0b013e31824b2ed8
复制
发表时间：
2012-04-01
影响因子：
7.2
通讯作者：
Lawrence, Hal C., III
中科院分区：
文献类型：
--
作者：
Chelmow, David;Waxman, Alan;Lawrence, Hal C., III
美国癌症协会、美国阴道镜检查和宫颈病理学会以及美国临床病理学家学会发布了修订后的宫颈癌筛查共识建议。这些新的建议整合了分子检测，并包括筛查的重大变化，特别是在30至65岁的女性中，没有并发症，现在可以每5年通过宫颈细胞学和高危人乳头瘤病毒检测的联合检测进行筛查，21-29岁的女性可以每3年单独进行宫颈细胞学筛查。修订后的建议包括澄清何时开始和停止筛查和管理接受子宫切除术的妇女。它们还阐明了共同检测结果的管理。新的建议达到了与以前建议相同的预防宫颈癌的程度。它们需要更少的筛查，对我们的患者来说更加方便。他们离每年进行巴氏试验的日子又近了一步，对宫颈癌筛查的需求减少，为在妇女健康访问期间关注许多其他重要的健康问题提供了一个令人兴奋的机会。（Obstet Gynecol 2012;119：695-9）DOI：10.1097/AOG.0b013e31824b2ed8
The American Cancer Society, the American Society for Colposcopy and Cervical Pathology, and the American Society of Clinical Pathologists have released revised consensus recommendations for cervical cancer screening. These new recommendations integrate molecular testing and include significant changes in screening, particularly in women from 30 to 65 years of age without complications who now may be screened every 5 years by co-testing with cervical cytology and high-risk human papillomavirus testing and women 21-29 years who may be screened with cervical cytology alone every 3 years. The revised recommendations include clarification on when to start and stop screening and management of women who have undergone hysterectomy. They also clarify the management of results of co-testing. The new recommendations achieve the same degree of protection against cervical cancer as previous recommendations. They require less screening and will be much more convenient for our patients. They are a further step away from the days of annual Pap tests, and the decreased requirements for cervical cancer screening pose an exciting opportunity for focusing on many other important health issues during the well woman visit. (Obstet Gynecol 2012;119:695-9) DOI: 10.1097/AOG.0b013e31824b2ed8